ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

ノルダゼパム

Nordiazepam

HCID 2997
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
1088-11-5
標準SMILES
O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1
InChIKey
AKPLHCDWDRPJGD-UHFFFAOYSA-N
分子式
C15H11ClN2O
平均分子量
270.71 g/mol
単同位体質量
270.0559907

概要

Nordazepam is a 1,4-benzodiazepinone having phenyl and chloro substituents at positions 5 and 7 respectively; it has anticonvulsant, anxiolytic, muscle relaxant and sedative properties but is used primarily in the treatment of anxiety. It has a role as an anxiolytic drug, an anticonvulsant, a sedative, a GABA modulator and a human metabolite. It is a 1,4-benzodiazepinone and an organochlorine compound.

名称と識別子

優先名称
Nordiazepam
IUPAC
7-chloro-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one
現地名
ノルダゼパム
英語名
Nordazepam
分子式
C15H11ClN2O
分子量
270.71

名称と別名

NordazepamNordiazepamdesmethyldiazepamNorprazepam1088-11-5N-DesmethyldiazepamN-DemethyldiazepamN-DeoxydemoxepamDemethyldiazepamMadar1-DemethyldiazepamN1-Desmethyldiazepam
名称をさらに表示
ノルプラゼパム7-クロロ-5-(フェニル)-1H-1,4-ベンゾジアゼピン-2(3H)-オン1,3-ジヒドロ-7-クロロ-5-(フェニル)-2H-1,4-ベンゾジアゼピン-2-オンノルダゼパムカルムダイ5-フェニル-7-クロロ-1H-1,4-ベンゾジアゼピン-2(3H)-オン7-クロロ-5-フェニル-1,3-ジヒドロ-2H-1,4-ベンゾジアゼピン-2-オン5-[フェニル]-7-クロロ-1H-1,4-ベンゾジアゼピン-2(3H)-オン1-デメチルジアゼパム7-クロロ-5-フェニル-1H-1,4-ベンゾジアゼピン-2(3H)-オンデメチルジアゼパム7-クロロ-2,3-ジヒドロ-5-フェニル-1H-1,4-ベンゾジアゼピン-2-オンノルジアゼパム5-フェニル-7-クロロ-1,3-ジヒドロ-2H-1,4-ベンゾジアゼピン-2-オン1,3-ジヒドロ-7-クロロ-5-フェニル-2H-1,4-ベンゾジアゼピン-2-オンデアルキルプラゼパム5-(フェニル)-7-クロロ-1H-1,4-ベンゾジアゼピン-2(3H)-オン7-クロロ-1,3-ジヒドロ-5-フェニル-2H-1,4-ベンゾジアゼピン-2-オンデスアルキルプラゼパムスチルニNDZNDDDmdzA 101NordazCalmday
StilnyNordazepamumPraxadiumDemadarNordazepam CIV7-Chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one7-chloro-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-oneN-Descyclopropylmethylprazepam

物性

構造計算による物性

XLogP
2.9
極性表面積
41.5 Ų
水素結合供与体数
1
水素結合受容体数
2
回転可能結合数
1
重原子数
19
形式電荷
0
複雑度
376

実験および物理化学的性質

Chemical ClassesPharmaceutical
Drugs · 5 件

DEA NFLIS-Drug Category -> Benzodiazepines

DEA Schedule IV Controlled Substance -> Depressants

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals -> Benzodiazepines

Pharmaceuticals -> Synthetic Cannabinoids or Psychoactive Compounds

LogP2.8
Solubility>40.6 [ug/mL] (The mean of the results at pH 7.4)
Human DrugsPharmaceuticals
Collision Cross Section160.1 Ų [M+H]+ [CCS Type: TW; Method: Major Mix IMS/Tof Calibration Kit (Waters)]

物理化学的性質

融点
208 · 208-210°C
沸点
453.1 · 453.1±45.0 °C(Predicted)
比重(密度)
1.2576 · 1.2576 (rough estimate)
屈折率
1.633 · 1.6330 (estimate)
闪点
11 °C · 11 °C
貯蔵温度
2 · 2-8°C
溶解性
10 mg/mL · DMSO:>10mg/mL

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 5 件

This chemical does not meet GHS hazard criteria for 8.3% (4 of 48) of reports.

Warning

H302 (89.6%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 48 reports by companies from 4 notifications to the ECHA C&L Inventory.

危険有害性情報

Regulatory Information · 3 件

DEA schedule IV controlled substance

REACH registered substance: Nordazepam (EC: 214-123-4)

2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-5-phenyl-: Does not have an individual approval but may be used under an appropriate group standard

Hazard Classes and CategoriesAcute Tox. 4 (89.6%)

毒性情報

Treatment · 1 件

General supportive measures should be employed, along with intravenous fluids, and an adequate airway maintained. Hypotension may be combated by the use of norepinephrine or metaraminol. Dialysis is of limited value. Flumazenil (Anexate) is a competitive benzodiazepine receptor antagonist that can be used as an antidote for benzodiazepine overdose. In particular, flumazenil is very effective at reversing the CNS depression associated with benzodiazepines but is less effective at reversing respiratory depression. Its use, however, is controversial as it has numerous contraindications. It is contraindicated in patients who are on long-term benzodiazepines, those who have ingested a substance that lowers the seizure threshold, or in patients who have tachycardia or a history of seizures. As a general rule, medical observation and supportive care are the mainstay of treatment of benzodiazepine overdose. Although benzodiazepines are absorbed by activated charcoal, gastric decontamination with activated charcoal is not beneficial in pure benzodiazepine overdose as the risk of adverse effects often outweigh any potential benefit from the procedure. It is recommended only if benzodiazepines have been taken in combination with other drugs that may benefit from decontamination. Gastric lavage (stomach pumping) or whole bowel irrigation are also not recommended.

化学と産業

薬理情報

ATC Code · 3 件

N05BA16

N - Nervous system

QN - Nervous system

Metabolism/MetabolitesNordiazepam has known human metabolites that include Oxazepam.
MeSH Pharmacological Classification · 2 件

Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here.

Substances that do not act as agonists or antagonists but do affect the GAMMA-AMINOBUTYRIC ACID receptor-ionophore complex. GABA-A receptors (RECEPTORS, GABA-A) appear to have at least three allosteric sites at which modulators act: a site at which BENZODIAZEPINES act by increasing the opening frequency of GAMMA-AMINOBUTYRIC ACID-activated chloride channels; a site at which BARBITURATES act to prolong the duration of channel opening; and a site at which some steroids may act. GENERAL ANESTHETICS probably act at least partly by potentiating GABAergic responses, but they are not included here.

Tissue LocationsKidney
Cellular LocationsCytoplasm

用途と製造

Use Classification · 2 件

Pharmaceuticals

Pharmaceuticals -> Transformation products

上流・下流製品情報

上流原料

ベンゾフェノンジフェニルアミン

関連反応

32 件
反応記録を作成
HRID 103397 の反応式
HRID 103397生成物として
HRID 106654 の反応式
HRID 106654生成物として
HRID 262942 の反応式
HRID 262942生成物として
HRID 262943 の反応式
HRID 262943反応物として
HRID 328109 の反応式
HRID 328109反応物として
HRID 462039 の反応式
HRID 462039反応物として
HRID 663836 の反応式
HRID 663836反応物として
HRID 704543 の反応式
HRID 704543生成物として
前へ1 / 4 ページ

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート

データベース識別子

CAS
1088-11-5
PubChem CID
2997
DTXSID
DTXSID2049000
ChEMBL
CHEMBL523
ChEBI
CHEBI:111762
UNII
67220MCM01
EC Number
214-123-4
Nikkaji
J7.250H
酸解離定数(Pka)
3.5 · pKa 3.5 12.0 (5%MeOH in H2O t=20 I=0.15) (Uncertain)
外見
ニート&_&パウダー
色
白から薄い黄褐色
主な用途
臨床検査
InChI
1S/C15H11ClN2O/c16-11-6-7-13-12(8-11)15(17-9-14(19)18-13)10-4-2-1-3-5-10/h1-8H,9H2,(H,18,19)
InChIKey
AKPLHCDWDRPJGD-UHFFFAOYSA-N
SMILES
Clc1ccc2NC(=O)CN=C(c3ccccc3)c2c1
LogP
2.93 · 2.930
NISTの化学物質情報
Nordazepam(1088-11-5)
EPAの化学物質情報
2 H-1,4-Benzodiazepin-2-one, · 2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-5-phenyl- (1088-11-5)

化学的性質

化学的特性Off-White Solid

Toxicity Summary · 1 件

Benzodiazepines bind nonspecifically to benzodiazepine receptors BNZ1, which mediates sleep, and BNZ2, which affects affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects of GABA by increasing GABA affinity for the GABA receptor. Binding of the inhibitory neurotransmitter GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 4 件

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

Nordazepam

DILI Positive

DOI:10.1016/j.drudis.2019.09.022

USGS Health-Based Screening Levels for Evaluating Water-Quality · 3 件

Nordiazepam

Pharmaceutical

Smith, C.D. and Nowell, L.H., 2024. Health-Based Screening Levels for evaluating water-quality data (3rd ed.). DOI:10.5066/F71C1TWP

安全データ

wgk
3
rtecs
DF1750000
ridadr
3249
毒性
LD50 in mice (mg/kg): 2750 orally, >400 i.p. (Randall); LD50 in mice, rats (mg/kg): 1300, >5200 orally (company communication)
hs_code
2933910000
risk_code
22-39/23/24/25-23/24/25-11
hazard_code
Xn,T,F
safety_code
7-16-36/37-45
hazard_class
6.1(b)
packing_group
III
Hazard Classifications
Acute Tox. 3 DermalAcute Tox. 3 InhalationAcute Tox. 3 OralFlam. Liq. 2STOT SE 1
ストレージクラス
3 - Flammable liquids
ヘキサメチレンテトラミン
酢酸

下流製品

1,3-ジヒドロ-7-クロロ-5-フェニル-2H-1,4-ベンゾジアゼピン-2-チオンピナゼパム

補足説明

定義ChEBI: A 1,4-benzodiazepinone having phenyl and chloro substituents at positions 5 and 7 respectively; it has anticonvulsant, anxiolytic, muscle relaxant and sedative properties but is used primarily in the treatment of anxiety.